All Stories

  1. Periodontal Bacteria and Outcomes Following Aneurysmal Subarachnoid Hemorrhage: A Prospective Observational Analysis
  2. Circulating miR-223-3p as an Independent Biomarker of Recurrent Thrombotic Risk After Ischemic Stroke
  3. Immune Checkpoint Dysregulation in Aneurysmal Subarachnoid Hemorrhage: A Prospective Study of sCTLA-4 and sPD-L1 as Biomarkers of Symptomatic Vasospasm
  4. Biomedical Applications of 3D‐Printed Polyamide: A Systematic Review
  5. Serum Desmosine Levels Might Be Associated with the Size of Ruptured Cerebral Aneurysms in Patients with Aneurysmal Subarachnoid Hemorrhage—A Preliminary Study
  6. Altered Pattern of Serum N-Glycome in Subarachnoid Hemorrhage and Cerebral Vasospasm
  7. Effects of Aneurysmal Subarachnoid Hemorrhage in Patients Without In-Hospital Infection on FABP-I, LBP, and sCD-14
  8. The Difference in Serum Metabolomic Profiles between the Good and Poor Outcome Groups at 3 Months in the Early and Late Phases of Aneurysmal Subarachnoid Hemorrhage
  9. Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches
  10. Gravity sedimentation reveals functionally and morphologically different platelets in human blood
  11. Acute Phase Protein Orosomucoid (Alpha-1-Acid Glycoprotein) Predicts Delayed Cerebral Ischemia and 3-Month Unfavorable Outcome after Aneurysmal Subarachnoid Hemorrhage
  12. Different Kinetics of Serum ADAMTS13, GDF-15, and Neutrophil Gelatinase-Associated Lipocalin in the Early Phase of Aneurysmal Subarachnoid Hemorrhage
  13. Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome
  14. Adverse Reactions after Booster SARS-CoV-2 Vaccination Have Less Impact on Antibody Response than after Basic Vaccination Scheme
  15. Serum Periostin May Help to Identify Patients with Poor Collaterals in the Hyperacute Phase of Ischemic Stroke
  16. Biomarker Associations in Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage
  17. General Anesthesia-Related Drop in Diastolic Blood Pressure May Impact the Long-Term Outcome in Stroke Patients Undergoing Thrombectomy
  18. Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up
  19. Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
  20. Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19
  21. Cerebral and Systemic Stress Parameters in Correlation with Jugulo-Arterial CO2 Gap as a Marker of Cerebral Perfusion during Carotid Endarterectomy
  22. Fatty Acid-Binding Protein 3 and CXC-Chemokine Ligand 16 are Associated with Unfavorable Outcome in Aneurysmal Subarachnoid Hemorrhage
  23. Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms
  24. l-arginine, asymmetric and symmetric dimethylarginine for early outcome prediction in unselected cardiac arrest victims: a prospective cohort study
  25. Increased level of LIGHT/TNFSF14 is associated with survival in aneurysmal subarachnoid hemorrhage
  26. Capability of stroke scales to detect large vessel occlusion in acute ischemic stroke : A pilot study
  27. Detection of silent cerebral microcirculatory abnormalities in patients with manifest ischemic coronary disease: a perfusion brain MRI study combined with dipyridamole stress
  28. Detailed severity assessment of Cincinnati Prehospital Stroke Scale to detect large vessel occlusion in acute ischemic stroke
  29. Detailed severity assessment of Cincinnati Prehospital Stroke Scale to detect large vessel occlusion in acute ischemic stroke
  30. Associations between serum L-arginine and ficolins in the early phase of acute ischemic stroke – A pilot study
  31. Risk analysis of post-procedural intracranial hemorrhage based on STAY ALIVE Acute Stroke Registry
  32. Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome
  33. Awake Sedation With Propofol Attenuates Intraoperative Stress of Carotid Endarterectomy in Regional Anesthesia
  34. A citokeratin-18 sejthalálmarker vizsgálata sikeres cardiopulmonalis resuscitatión átesett betegpopulációban
  35. Personalised antiplatelet therapy as a secondary prophylaxis of ischemic stroke
  36. Subacute Elevation of Plasma Level of Caspase-Cleaved Cytokeratin-18 is Associated with Hemorrhagic Transformation and Functional Outcome in Ischemic Stroke
  37. L-arginine pathway metabolites can discriminate paroxysmal from permanent atrial fibrillation in acute ischemic stroke
  38. Role of microparticles in the exacerbation of COPD
  39. Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes
  40. Cost-effectiveness of anesthesia maintained with sevoflurane or propofol with and without additional monitoring: a prospective, randomized controlled trial
  41. Relationship between Cardiac Troponin and Thrombo-Inflammatory Molecules in Prediction of Outcome after Acute Ischemic Stroke
  42. Teriflunomide for multiple sclerosis in real-world setting
  43. C‐reactive protein in the detection of post‐stroke infections: systematic review and individual participant data analysis
  44. l -Arginine Pathway Metabolites Predict Need for Intra-operative Shunt During Carotid Endarterectomy
  45. Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke
  46. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study
  47. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions
  48. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker
  49. Early Dynamics of P-selectin and Interleukin 6 Predicts Outcomes in Ischemic Stroke
  50. The L-arginine Pathway in Acute Ischemic Stroke and Severe Carotid Stenosis: Temporal Profiles and Association with Biomarkers and Outcome
  51. Plasma somatostatin-like immunoreactivity increases in the plasma of septic patients and rats with systemic inflammatory reaction: Experimental evidence for its sensory origin and protective role
  52. Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system
  53. “Cerebrovascular stressing”: dipyridamole-induced S100B elevation predicts ischemic cerebrovascular events
  54. Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke
  55. Relationship between C-reactive protein and early activation of leukocytes indicated by leukocyte antisedimentation rate (LAR) in patients with acute cerebrovascular events
  56. Increased levels of baseline biomarkers reflecting platelet and endothelial activation predict early cognitive dysfunction after lung surgery
  57. Deficient leucocyte antisedimentation is related to post-stroke infections and outcome
  58. Role of the leukocyte antisedimentation rate in prediction of early recognition of post-stroke infection